Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asymchem Laboratories Tianjin Co (OTCPK:ASLTY) Future 3-5Y EPS without NRI Growth Rate Explanation
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
Asymchem Laboratories Tianjin Co Future 3-5Y EPS without NRI Growth Rate Related Terms
ASLTY vs VRTX, REGN, RVMD: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asymchem Laboratories Tianjin Co Future 3-5Y EPS without NRI Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Asymchem Laboratories Tianjin Co's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 25.05 mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a Future 3-5Y EPS without NRI Growth Rate of 25.05 as of Aug. 30, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Asymchem Laboratories Tianjin Co and its competitors. According to the industry distribution chart, Asymchem Laboratories Tianjin Co ranks #181 out of 404 companies in the Biotechnology industry, placing it in the top 44.8%.
Is Asymchem Laboratories Tianjin Co's Future 3-5Y EPS without NRI Growth Rate too high?
Asymchem Laboratories Tianjin Co's current Future 3-5Y EPS without NRI Growth Rate is 25.05. The Biotechnology industry median Future 3-5Y EPS without NRI Growth Rate is 22.01. Asymchem Laboratories Tianjin Co's value of 25.05 is 13.8% above this industry median. Based on the distribution chart, Asymchem Laboratories Tianjin Co ranks #181 out of 404 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's Future 3-5Y EPS without NRI Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Asymchem Laboratories Tianjin Co ranks #181 out of 404 companies for Future 3-5Y EPS without NRI Growth Rate. This puts Asymchem Laboratories Tianjin Co in the upper half of its industry. The industry median Future 3-5Y EPS without NRI Growth Rate is 22.01. Asymchem Laboratories Tianjin Co's value of 25.05 is 13.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Biotechnology company?
The median Future 3-5Y EPS without NRI Growth Rate among Biotechnology companies is 22.01, based on 404 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asymchem Laboratories Tianjin Co's current Future 3-5Y EPS without NRI Growth Rate of 25.05 is 13.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Asymchem Laboratories Tianjin Co and its competitors. For the Biotechnology industry, the median Future 3-5Y EPS without NRI Growth Rate is 22.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asymchem Laboratories Tianjin Co's current Future 3-5Y EPS without NRI Growth Rate is 25.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.28, compared to a current price of $8.15 — trading 90.4% above its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 25.05 and 13.8% above the Biotechnology industry median of 22.01. Asymchem Laboratories Tianjin Co's overall GF Score™ is 63/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current Future 3-5Y EPS without NRI Growth Rate is 25.05 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued.
The current stock price of $8.15 is trading 90.4% above its estimated GF Value™ of $4.28.
GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.
Key valuation signals for ASLTY:
Future 3-5Y EPS without NRI Growth Rate: 25.05
GF Value™: $4.28 vs. price of $8.15 (90.4% above fair value)
Industry Position: 13.8% above the Biotechnology median (#181 of 404)
No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
63GF Score
Get the complete analysis for ASLTY
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASLTY has been successfully added to your 
